Upcoming Events

By Dr. Robert Katz, LSI Board Chair and LSI Medical Advisory Board Chair (CAR T-cell therapy, typically used in cancer treatment, is a form of immunotherapy.In CAR T-cell therapy, blood […]

The lupus community has been fortunate to benefit from new drugs and treatments that have made a huge impact on the quality of life and longevity of patients. How did […]

In those who become infected with COVID-19, treatments are now available. All treatments are more effective if given as soon as possible after a positive COVID-19 test.

Viruses constantly change through mutation and sometimes these mutations result in a new variant of the virus. Some variants emerge and disappear while others persist.

The COVID-19 vaccines are effective, including a booster dose, in vulnerable lupus patients, including those taking immunosuppressive therapies.

By Dr. Robert Katz Medical Advisory Board The effects of exercise intervention on health-related quality of life in patients with systemic lupus in the journal Healthcare. In this study, 1,058 [...]

By Dr. Robert Katz Medical Advisory Board Pharmacies are now offering booster shots for immunocompromised patients. Many lupus patients qualify because they are being treated with prednisone and [...]

By Dr. Robert Katz According to the CDC, the Delta variant of COVID-19 is more contagious – more than 2x as contagious as previous variants; some data suggest the Delta […]

What is SAPHNELO and how does it work?SAPHNELO is a first-in-class type I interferon (IFN) receptor antagonist, a human monoclonal antibody that binds to subunit 1 of the type I […]

By Dr. Robert Katz Europe has now approved the use of Benlysta to treat children with lupus. Benlysta has the generic name belimumab. The “mab” at the end indicates it […]